Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carmell Co. stock logo
CTCX
Carmell
$2.55
+8.5%
$2.94
$0.17
$1.27
$4.13M0.514.65 million shs51,504 shs
Inogen, Inc stock logo
INGN
Inogen
$7.46
-2.7%
$6.80
$5.70
$13.33
$207.40M1.72284,956 shs182,241 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$13.29
+3.1%
$17.97
$5.85
$25.35
$229.01M2.14360,714 shs194,871 shs
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$4.20
-1.2%
$3.86
$2.03
$7.05
$222.56M2.44128,461 shs98,085 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carmell Co. stock logo
CTCX
Carmell
-2.08%-15.77%-58.77%-21.67%+135.00%
Inogen, Inc stock logo
INGN
Inogen
-2.74%+15.12%+14.07%+22.50%-38.75%
Outset Medical, Inc. stock logo
OM
Outset Medical
+3.10%+3.83%-26.57%-31.85%+6.36%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-1.18%-0.94%+19.66%+18.31%-27.46%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Carmell Co. stock logo
CTCX
Carmell
N/AN/AN/AN/AN/AN/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
4.3861 of 5 stars
3.35.00.03.92.71.70.6
Outset Medical, Inc. stock logo
OM
Outset Medical
1.3739 of 5 stars
3.52.00.00.01.40.00.0
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
1.6505 of 5 stars
1.23.00.00.03.83.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Carmell Co. stock logo
CTCX
Carmell
0.00
N/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
2.50
Moderate Buy$11.0047.45% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
3.00
Buy$24.6785.60% Upside
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
2.43
Hold$4.271.59% Upside

Current Analyst Ratings Breakdown

Latest CTCX, OM, SGHT, and INGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/8/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$3.00 ➝ $5.00
8/7/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$21.00 ➝ $22.00
7/15/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$3.00 ➝ $4.00
7/14/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$37.00
6/18/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.50 ➝ $4.00
6/16/2025
Inogen, Inc stock logo
INGN
Inogen
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$14.00
6/15/2025
Inogen, Inc stock logo
INGN
Inogen
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$14.00
5/22/2025
Inogen, Inc stock logo
INGN
Inogen
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Moderate Buy$12.00
5/22/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.20 ➝ $3.60
5/21/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.00
(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Carmell Co. stock logo
CTCX
Carmell
$32.84K1,623.31N/AN/A$1.07 per share2.38
Inogen, Inc stock logo
INGN
Inogen
$335.70M0.60N/AN/A$7.38 per share1.01
Outset Medical, Inc. stock logo
OM
Outset Medical
$113.69M2.08N/AN/A$8.50 per share1.56
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$79.87M2.75N/AN/A$1.34 per share3.13
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Carmell Co. stock logo
CTCX
Carmell
-$15.44MN/A0.00N/AN/A-217.50%-50.22%N/A
Inogen, Inc stock logo
INGN
Inogen
-$35.89M-$1.06N/AN/AN/A-7.58%-13.77%-8.52%N/A
Outset Medical, Inc. stock logo
OM
Outset Medical
-$127.98M-$20.29N/AN/A-82.06%-97.17%-32.84%N/A
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$51.51M-$0.96N/AN/AN/A-64.23%-59.38%-36.43%N/A

Latest CTCX, OM, SGHT, and INGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Inogen, Inc stock logo
INGN
Inogen
-$0.22-$0.15+$0.07-$0.15$90.40 million$92.28 million
8/7/2025Q2 2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$0.25-$0.23+$0.02-$0.23$18.18 million$19.56 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Carmell Co. stock logo
CTCX
Carmell
N/AN/AN/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Carmell Co. stock logo
CTCX
Carmell
N/A
0.31
0.29
Inogen, Inc stock logo
INGN
Inogen
N/A
3.03
2.67
Outset Medical, Inc. stock logo
OM
Outset Medical
0.63
7.47
6.05
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
0.57
10.01
9.49

Institutional Ownership

CompanyInstitutional Ownership
Carmell Co. stock logo
CTCX
Carmell
24.22%
Inogen, Inc stock logo
INGN
Inogen
89.94%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
55.51%

Insider Ownership

CompanyInsider Ownership
Carmell Co. stock logo
CTCX
Carmell
29.00%
Inogen, Inc stock logo
INGN
Inogen
1.46%
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
30.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Carmell Co. stock logo
CTCX
Carmell
1420.91 million14.84 millionNot Optionable
Inogen, Inc stock logo
INGN
Inogen
1,03027.04 million26.65 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
52017.77 million17.34 millionNot Optionable
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
21052.37 million36.19 millionOptionable

Recent News About These Companies

Sight Sciences, Inc. (NASDAQ:SGHT) Receives $4.27 Average PT from Analysts
Lake Street Upgrades Sight Sciences (SGHT)
Sight Sciences Reports Q2 2025 Financial Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Carmell stock logo

Carmell NASDAQ:CTCX

$2.55 +0.20 (+8.51%)
As of 08/15/2025

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Inogen stock logo

Inogen NASDAQ:INGN

$7.46 -0.21 (-2.74%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$7.45 -0.01 (-0.13%)
As of 08/15/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Outset Medical stock logo

Outset Medical NASDAQ:OM

$13.29 +0.40 (+3.10%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$13.20 -0.08 (-0.64%)
As of 08/15/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Sight Sciences stock logo

Sight Sciences NASDAQ:SGHT

$4.20 -0.05 (-1.18%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$4.20 0.00 (0.00%)
As of 08/15/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.